Company Overview
- Website
- aveooncology.com
- Phone
- (857) 400-0101
- Employees
- 199
- Founded in
- 2001
- Industry
- BioTech/Drugs
- Stock Symbol
- NASDAQ:AVE
- NAICS Codes
-
32 - Manufacturing325 - Chemical Manufacturing3254 - Pharmaceutical and Medicine Manufacturing32541 - Pharmaceutical and Medicine Manufacturing
- SIC Codes
-
28 - Chemicals and Allied Products283 - Drugs
Financials & Stats
Revenue
$61B
Total Funding Amount
$502M
Recent News & Media
AVEO Oncology, an LG Chem company, Presents Three Posters at ASCO 2025 Annual Meeting
- Jun 3, 2025
- prnewswire.com
AVEO Oncology, an LG Chem company, Announces Three Poster Presentations at ASCO 2025 Annual Meeting
- Apr 28, 2025
- prnewswire.com
Blacklisting of Aveo Pharmaceuticals and Banning of Tapentadol and Carisoprodol Combination – Tafrodol or Royal 225
- Mar 2, 2025
- firstwordpharma.com
Public Alert No. 04/2025 – Public Alert on the Illegal Exportation and Sale of Opioids to West African Countries by Aveo Pharmaceuticals
- Feb 28, 2025
- firstwordpharma.com
Aveo pharmaceuticals suspended: Ghana government take action afta BBC Africa Eye opioid revelation
- Feb 26, 2025
- bbc.com
India bans drugs blamed for opioid crisis in West Africa
- Feb 24, 2025
- independent.co.uk
Who is AVEO Pharmaceuticals
AVEO Pharmaceuticals is a commercial-stage, oncology-focused biopharmaceutical company headquartered in Boston, Massachusetts. The company currently employs 199 individuals and reported $61.3 million in revenue. AVEO Pharmaceuticals is dedicated to developing and commercializing innovative cancer treatments. Their marketed product, FOTIVDA® (tivozanib), is an important option for adult patients with relapsed or refractory renal cell carcinoma (RCC) who have received at least two previous systemic therapies. The company is actively exploring the use of FOTIVDA in combination with immunotherapy for RCC and other types of cancer. In addition to FOTIVDA, AVEO has several other investigational programs in various stages of clinical development. AVEO Pharmaceuticals distinguishes itself through its commitment to diversity, equity, and inclusion. The company actively works to create a welcoming and representative environment for all employees. To learn more about AVEO Pharmaceuticals and their groundbreaking work in oncology, visit their website at aveooncology.com.